Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi ASCO Preview: Addressing Unmet Needs in Breast Cancer
BioSpace
Thu, 06/3/21 - 11:08 pm
Tags:
Sanofi, breast cancer, clinical trials, ASCO 2021
Sanofi looks to take Mylan to court, again, over EpiPen antitrust allegations
Fierce Pharma
Wed, 06/2/21 - 12:14 pm
Tags:
Sanofi, Mylan, EpiPens, antitrust, legal
Sanofi's venglustat fails another trial, ending pursuit of kidney disease
Fierce Biotech
Tue, 06/1/21 - 11:02 am
Tags:
Sanofi, venglustat, autosomal dominant polycystic kidney disease, kidney disease, clinical trials
Amgen follows Sanofi into a new dermatitis mechanism
EP Vantage
Tue, 06/1/21 - 10:58 am
Tags:
Amgen, Sanofi, atopic dermatitis, Ichnos, KHK4083, Kyowa Kirin
Sanofi and GSK take COVID-19 vaccine into Phase 3 study
Biopharma Reporter
Thu, 05/27/21 - 11:59 am
Tags:
Sanofi, GSK, clinical trials, vaccines, COVID-19
A 'springboard' to the future: Genentech, Sanofi and Alnylam execs sound off on pharma's evolving back-to-work plans
Fierce Pharma
Wed, 05/26/21 - 12:05 am
Tags:
pandemic, COVID-19, Genentech, Sanofi, Alnylam, remote work, human resources
A top analyst sees 'inflection point' in the other big vaccine race taking pharma by storm
Endpoints
Mon, 05/24/21 - 11:18 pm
Tags:
vaccines, COVID-19, inflection point, Pfizer, Moderna Therapeutics, JNJ, Merck, GSK, Sanofi
After Sanofi’s setbacks, Takeda eyes finish line with its dengue vaccine
Pharmaforum
Mon, 05/24/21 - 10:55 am
Tags:
Takeda, clinical trials, vaccines, dengue, Sanofi, Dengvaxia, TAK-003
ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca
BioSpace
Thu, 05/20/21 - 12:35 pm
Tags:
ASCO 2021, Sanofi, Sloane Kettering, Incyte, AstraZeneca, Exelixis, oncology
ASCO: Sanofi says early amcenestrant data could see it be 'endocrine backbone therapy' in breast cancer
Fierce Biotech
Wed, 05/19/21 - 11:24 pm
Tags:
ASCO 2021, Sanofi, breast cancer, Amcenestrant
Sanofi, GSK say revamped coronavirus vaccine is strong enough for final test
BioPharma Dive
Mon, 05/17/21 - 10:53 am
Tags:
Sanofi, GSK, COVID-19, vaccines, clinical trials
Sanofi, touting new data, sees 'best-in-class' case for Dupixent in pediatric asthma
Fierce Pharma
Mon, 05/17/21 - 10:46 am
Tags:
Sanofi, Dupixent, asthma, pediatric
Sanofi, Cellectis team up to pair Lemtrada with allogeneic CAR-Ts; Bristol Myers joins Evotec's drive to advance UK science
Endpoints
Thu, 05/13/21 - 11:59 pm
Tags:
Sanofi, Cellectis, allogeneic cells, CAR-T, alemtuzumab, Lemtrada
Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent
Fierce Biotech
Thu, 05/13/21 - 10:57 am
Tags:
Amgen, AstraZeneca, tezepelumab, asthma, severe asthma, Sanofi, Dupixent, FDA
Sanofi hit with charges of 'widespread' email deletion in legal saga stemming from Zantac recalls
Fierce Pharma
Wed, 05/12/21 - 11:10 am
Tags:
Sanofi, Zantac, FDA, legal
Validation for a drug class, and for Sanofi
EP Vantage
Wed, 05/12/21 - 10:44 am
Tags:
Sanofi, Serds, breast cancer, Amcenestrant, Radius Health, Elacestrant, Roche, Giredestrant, AstraZeneca, Camizestrant
Sanofi begins three-year immunology R&D tie-up with Stanford
Pharmaforum
Thu, 05/6/21 - 10:45 am
Tags:
Sanofi, Sanford, R&D, immunology, inflammation
AbbVie's Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along
Fierce Pharma
Wed, 05/5/21 - 10:50 am
Tags:
AbbVie, Humira, DTC advertising, television ads, Sanofi, Dupixent, Novo Nordisk, Rybelsus
Biotech Avrobio plans head-to-head Fabrazyme trial after FDA changes path to market
Fierce Biotech
Mon, 05/3/21 - 10:59 am
Tags:
Avrobio, Fabry disease, gene therapy R&D, Sanofi, AVR-RD-01
Biopharma Companies Wrestle with Staffing Situations and Shortages from Pandemic
BioSpace
Thu, 04/29/21 - 10:45 pm
Tags:
COVID-19, pandemic, Sanofi, Pfizer, Moderna Therapeutics, Novartis, Lonza

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.